Division of Translational Cancer Research
171 – 180 of 692
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Patient-derived models : Advanced tools for precision medicine in neuroblastoma
- Contribution to journal › Article
-
Mark
The Lund taxonomy for bladder cancer classification – from gene expression clustering to cancer cell molecular phenotypes, and back again
- Contribution to journal › Scientific review
-
Mark
Unconventional Source of Neurotoxic Protein Aggregation from Organelle Off-Target Bax∆2 in Alzheimer's Disease
- Contribution to journal › Article
-
Mark
Distinct Cholesterol Localization in Glioblastoma Multiforme Revealed by Mass Spectrometry Imaging
- Contribution to journal › Article
-
Mark
MOLECULAR MARKERS OF RED BONE MARROW AND MARROW ADIPOSE TISSUE AND THEIR APPLICATION IN GEOLOGICAL SAMPLES
(2023) 31st International Meeting on Organic Geochemistry, IMOG 2023
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Acoustophoresis enrichment of tumor cell clusters in blood of patients with metastatic prostate cancer
(2023) The 27th International Conference on Miniaturized Systems for Chemistry and Life Sciences (µTAS 2023)
- Contribution to conference › Abstract
-
Mark
Acoustophoresis enriches tumor cell clusters in blood of patients with prostate cancer
(2023) Acoustofluidics Conference 2023, St. Louis USA
- Contribution to conference › Abstract
-
Mark
Comparison of SP142 and 22C3 PD-L1 assays in a population-based cohort of triple-negative breast cancer patients in the context of their clinically established scoring algorithms
- Contribution to journal › Article
-
Mark
Quality of Life in Patients with High-grade Non–muscle-invasive Bladder Cancer Undergoing Standard Versus Reduced Frequency of Bacillus Calmette-Guérin Instillations : The EAU-RF NIMBUS Trial
- Contribution to journal › Article
-
Mark
Apalutamide plus androgen deprivation therapy in clinical subgroups of patients with metastatic castration-sensitive prostate cancer : A subgroup analysis of the randomised clinical TITAN study
- Contribution to journal › Article
